Concepedia

Melissa L. Boby

ML

Statistics

Publications

7

Citations

424

H-Index

7

Active since

2014

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

University of Johannesburg

Diamond Light Source

Weizmann Institute of Science

Melissa L. Boby is an author at Memorial Sloan Kettering Cancer Center specializing in pharmacology, drug discovery, and medicine.

ORCID

Top concepts

Publications per year

2014–2023

7

Publications

7

Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors

Melissa L. Boby, D. Fearon, Matteo P. Ferla et al. · Science · 2023 · 158 citations · Full text

Design and evaluation of novel glutaminase inhibitors

Lee McDermott, Prema Iyer, Shawn Rimer et al. · Bioorganic & Medicinal Chemistry · 2016 · 72 citations · Full text

, , +4

Best Practices for Constructing, Preparing, and Evaluating Protein-Ligand Binding Affinity Benchmarks [Article v1.0]

David F. Hahn, Christopher I. Bayly, Melissa L. Boby et al. · Living Journal of Computational Molecular Science · 2022 · 72 citations · Full text

Open Science Discovery of Potent Non-Covalent SARS-CoV-2 Main Protease Inhibitors

Melissa L. Boby, D. Fearon, Matteo P. Ferla et al. · 2020 · 70 citations · Full text

, , +16

Turning high-throughput structural biology into predictive inhibitor design

Kadi L. Saar, William McCorkindale, D. Fearon et al. · Proceedings of the National Academy of Sciences · 2023 · 22 citations · Full text

1–5 of 7